Autopsy report · NCT02509273

Efficacy, Safety and Pharmacokinetic Study of Intravenous Clonidine Versus Midazolam for Sedation in Paediatric Patients

“lack of recruitment”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 1 month before it started.
• Ran for about 2 years 5 months before it stopped.
• 28 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University of Erlangen-Nürnberg Medical School

Sponsor type

University, hospital or other

Conditions

Sedation in Intensive Care

Interventions

Clonidine; Midazolam

Participants

28

Sites

10

Countries

Czechia, Estonia, Germany, Italy, Netherlands, Spain, Sweden

Trials that died the same way

• Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation
  “lacking recruitment” (96% match in meaning)
• Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
  “Inadequate recruitment” (93% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.